Albert Lab

2026-2031, Targeting neuroplasticity to overcome treatment-resistant depression. Canadian Institutes of Health Research

2025-2027, Targeting serotonin to improve depression and dementia in heart and Alzheimer disease. Brain Heart Interconnectome.

2025-2026, Early raphe nucleus pathology and depression with a-syn seeding: A novel approach to targeting mTOR for prodromal Parkinsonism. (PI: Shawn Hayley) Parkinson Research Consortium.

2025-2029, Enhancing neuroplasticity for behavioral and cognitive recovery after stroke. Heart and Stroke Foundation, Canada.

2021-2026, Astroglial cells as mediators of sex and hormone- dependent differences in depressive like behaviours. (PI: Natalina Salmaso) Canadian Institutes of Health Research